Kinetics of filamentation of Escherichia coli induced by different sub-MICs of ceftibuten at different times. 1993

P C Braga, and G Piatti
Center for Respiratory Pharmacology, School of Medicine, University of Milan, Italy.

Subinhibitory concentrations of some antibiotics are able to inhibit adhesion of bacteria to human host cells, to facilitate phagocytosis and to modify the shape of the bacteria cell wall, e.g., variable degrees of filamentation occur frequently in gram-negative bacteria. The kinetics of filamentation of Escherichia coli were investigated by incubation for various periods up to 18 h, with different subinhibitory concentrations of ceftibuten, from 1/2 to 1/128 of the MIC, corresponding to 0.25-0.003 micrograms/ml. Normal shapes, short and long filamentation and bacterial ghosts were observed. The morphological changes in the bacterial cells were influenced by the duration of exposure and by the antibiotic concentration. The greatest filamentation did not occur at 1/2 MIC, the concentration of ceftibuten closest to the MIC, but at 1/8 MIC, and filamentation plus ghosts were maximal between 8 and 18 h of incubation. The morphological changes observed clearly show that ceftibuten has a greater affinity for and impairs the function of penicillin-binding protein 3 (involved in synthesis of peptidoglycan for cross walls) more than other cephalosporins, such as cephaloridine or cefoxitin.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002473 Cell Wall The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents. Cell Walls,Wall, Cell,Walls, Cell
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077722 Ceftibuten A cephalosporin antibacterial agent that is used in the treatment of infections, including urinary-tract and respiratory-tract infections. 7-(2-(2-amino-4-thiazolyl)-4-carboxy-2-butenoylamino)-3-cephem-4-carboxylic acid,7432 S,7432-S,Cedax,SCH 39720,SCH-39720,SCH39720
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

P C Braga, and G Piatti
February 1968, Journal of bacteriology,
P C Braga, and G Piatti
May 1994, Antimicrobial agents and chemotherapy,
P C Braga, and G Piatti
February 2002, Journal of chemotherapy (Florence, Italy),
P C Braga, and G Piatti
February 1990, Antimicrobial agents and chemotherapy,
P C Braga, and G Piatti
September 2019, International microbiology : the official journal of the Spanish Society for Microbiology,
P C Braga, and G Piatti
February 2003, Applied and environmental microbiology,
P C Braga, and G Piatti
December 2006, Proceedings of the National Academy of Sciences of the United States of America,
P C Braga, and G Piatti
October 1992, Journal of general microbiology,
Copied contents to your clipboard!